Medical Affairs & Safety
Senior Director, Medical Affairs
Lead medical affairs for a targeted radioligand therapy ahead of launch. You will build the field team, the evidence plan and the company's relationships with the nuclear medicine community.
A typical mandate
The company develops radioligand therapies that deliver a therapeutic isotope directly to tumor cells. Its lead program is in a Phase 3 study in neuroendocrine tumors, with a companion imaging agent in development. Launch depends on treatment sites being ready, and medical affairs leads that work.
What the role owns
- Build the medical affairs plan for launch, including scientific communication and education
- Hire and lead a field medical team covering nuclear medicine and oncology
- Develop relationships with nuclear medicine physicians, radiation safety officers and oncologists
- Lead the integrated evidence plan, including real-world and investigator-initiated studies
- Support site readiness on dosimetry, radioactive material handling and patient pathways
- Partner with commercial and regulatory on compliant scientific exchange
What great candidates bring
- MD, PharmD or PhD with 10+ years in medical affairs
- Oncology medical affairs experience, with radiopharmaceutical or nuclear medicine exposure strongly preferred
- Pre-launch and launch experience
- Experience building and leading field medical teams
- Fluency with the PhRMA Code and OPDP expectations for scientific exchange
- Comfort working with sites where radiology, oncology and radiation safety meet
Why it matters
- Reports to the Chief Medical Officer
- Equity at a company approaching its first approval
- A defining role in how treatment sites adopt this therapy
- Hybrid schedule, with regular site travel
Related profiles